Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
977 people get THC articles and Market Currents by email alert.
Get email alerts on THC »
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Tenet Eyes HealthscopeZacks Investment Research • Wed, Jun 2, 2010
-
Tenet Healthcare Tops Estimates as Revenues RiseZacks Investment Research • Thu, Feb 25, 2010
-
Swing Traders Can Short or Wait for a Pullback on Tenet HealthcareSimit Patel • Thu, Aug 20, 2009
-
Tenet Says It Has the Resources for a TurnaroundRoy Mehta • Wed, Aug 29, 2007
-
Physician, Heal Thyself: Tenet Healthcare Makes Good With the SECBelvedere • Mon, Apr 9, 2007
To learn more about Seeking Alpha Pro, click here.
-
Tuesday Options Brief: AOL, THC & AAPInteractive Brokers • Tue, Nov 6, 2012
-
U.S. Healthcare: The Matrix Of DeclineNicholas Puri (PuriCassar) • Tue, Oct 23, 2012
-
5 Stocks With Insider Buys Filed On October 17 To ConsiderMarkus Aarnio • Thu, Oct 18, 2012
-
Insiders Bought These Shares On October 17StockPandit • Thu, Oct 18, 2012
-
Tenet Healthcare Q2 2010 Earnings Call TranscriptTue, Aug 3, 2010
-
Tenet Healthcare Q1 2010 Earnings Call TranscriptWed, May 5, 2010
-
Tenet Healthcare Corp. Q4 2009 Earnings Call TranscriptTue, Feb 23, 2010
-
Tenet Healthcare Corporation Q3 2009 Earnings Call TranscriptTue, Nov 3, 2009
-
Tenet Healthcare Corp. Q2 2009 Earnings Call TranscriptTue, Aug 4, 2009
-
Business Wire (Wed, 11:00AM)
-
at CNBC.com (Jun 6, 2013)
-
Business Wire (May 15, 2013)
-
Business Wire (May 15, 2013)
-
Business Wire (May 8, 2013)
-
at MarketWatch.com (Apr 30, 2013)
-
at MarketWatch.com (Apr 30, 2013)
-
Business Wire (Apr 30, 2013)
-
at CNBC.com (Apr 29, 2013)
-
at MarketWatch.com (Apr 29, 2013)
-
at MarketWatch.com (Apr 29, 2013)
-
at CNBC.com (Apr 29, 2013)
-
at CNBC.com (Apr 29, 2013)
-
at CNBC.com (Apr 26, 2013)
-
Business Wire (Apr 11, 2013)
-
at MarketWatch.com (Apr 10, 2013)
-
at CNBC.com (Apr 10, 2013)
-
at MarketWatch.com (Apr 9, 2013)
THC vs. ETF Alternatives
Company Description
Tenet Healthcare Corporation is an investor-owned health care services company whose subsidiaries and affiliates principally operate general hospitals and related ancillary health care businesses. All of Tenet’s operations are conducted through its subsidiaries. (Unless the context otherwise... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Wednesday, June 12, 8:30 AM Deutsche Bank is fond of its Health Management (HMA) takeout thesis (previous) and now says "recent management turnover" and the activist agenda of the company's largest shareholder (Glenview, 13D filing) "significantly increase the probabilities HMA's board could put the company in play." $20/share seems like a reasonable figure to DB and based on analyst Darren Lehrich's recent note, Tenet (THC) could be the bidder. HMA upgraded to Buy (PT to $18 from $12). Shares +11.27% premarket. Comment! [Healthcare, On the Move]
- Thursday, June 6, 11:35 AM More interesting tidbits from Deutsche Bank's upgrade of Tenet Healthcare (THC +2.1%): Analyst Darren Lehrich (who spoke with management) says THC did not rule out "large-scale M&A (acquiring other investor-owned chains)," fueling some speculation about a deal for Health Management Associates (HMA +0.8%). A nice thought perhaps, but Lehrich says THC noted its recent strategy of "divesting rural assets," something HMA has a lot of. Comment! [On the Move, Healthcare, M&A]
- Thursday, June 6, 10:54 AM Tenet Healthcare (THC +1%) gets a boost from a Deutsche Bank upgrade to Buy from Hold (price target $55 from $49). Analyst Darren Lehrich says the risk/reward "seems very good" considering the company's "relative growth profile, cost savings, improving FCF, [and] accretive capital deployment." FY14 EPS estimate raised to $4.35 from $4.03 versus consensus of $3.60. Comment! [Healthcare]
- Tuesday, April 30, 11:22 AM More on Tenet Healthcare's (THC +2.2%) Q1: Shares trade higher after the company posts a narrow EPS beat. Excluding a restructuring, impairments, and costs related to acquisitions, the company managed to double its earnings thanks to "rapid" cost adjustments, CEO Trevor Fetter said, adding that the firm is witnessing a "soft volume environment." Competitors have reported similarly low Q1 admissions. THC also reaffirmed its FY13 guidance. (PR, Reuters) Comment! [Healthcare, Earnings, On the Move]
- Tuesday, April 30, 8:34 AM Tenet Healthcare (THC): Q1 EPS of $0.33 beats by $0.02. Revenue of $2.38B misses by $0.08B. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Monday, April 29, 10:08 AM Tenet Healthcare (THC +8.5%) moves sharply higher on a pair of upgrades, one from Baird (Outperform from Neutral) and one from UBS (Neutral to Buy). Medicare regulators issued a rule proposing a 0.8% reimbursement hike for hospitals Friday after the bell. Other hospital stocks moving higher in early trading: HCA +8% , HMA +5.9% . Comment! [Healthcare, On the Move]
-
Monday, April 29, 9:15 AM
Premarket gainers: SINA +22%. CPTS +20%. PPHM +8%. NIHD +8%. THC +7%. PBR +6%. HCA +9%. HMA +5%. MCO +5%. RDN +5%.
Losers: NTE -27%. GORO -9%. NBG -8%. RVLT -5%. Comment! [On the Move] - Wednesday, April 10, 11:02 AM In addition to Deutsche's downgrade of Tenet Healthcare (THC -4.7%), the firm also cuts Health Management (HMA -16.5%) and Community Health (CYH -4.8%) to Hold as well, citing pumped-up share prices due to overzealous investor enthusiasm for the US health-care overhaul. Comment! [Healthcare, On the Move]
- Wednesday, April 10, 9:49 AM Hospital stocks fall following Health Management's profit warning, with Tenet Healthcare (THC -4.2%) also hurt by a downgrade from Deutsche Bank, which cut the stock to "Hold" from "Buy." HCA -2.9%, UHS -0.4%, CYH -1.9%. 1 Comment [Healthcare, On the Move]
-
Tuesday, April 9, 5:56 PM
After-hours top gainers, as of 5:15 p.m.: ACTS +8%. PSUN +6%. PZE +5%. PSMT +4%. NAVB +3%.
After-hours top losers: SGYP -12%. HMA -11%. SEAC -10%. RLGY -7%. THC -5%. Comment! [On the Move] - Friday, March 8, 2:13 PM Tenet (THC +3.3%) shares move up today after CRT Capital boosts its rating to Buy and sets a $51 target. The firm cites a number of positive catalysts, including it's strong quarterly performance recently, improved free-cash flow and expected benefits from the health-care overhaul, whose positive impact hasn't even been felt yet. CRT says the Street may be significantly underestimating the power of upcoming reform measures, which aren't even set to kick in until 2015. 1 Comment [Healthcare, On the Move]
- Tuesday, February 26, 8:43 AM More on Tenet Healthcare (THC) Q4: swings to net profit of $49M from loss of $76M a year earlier, which included a $74M loss on the early repayment of debt. Adjusted EBITDA +16.7% to $336M. Net patient revenue per adjusted admission +2.8% to $11,866. Expects Q1 adjusted EBITDA of $250-290M as well as 2013 EBITDA of $1.325-1.425B, in line. Comment! [Earnings, Healthcare]
- Tuesday, February 26, 7:42 AM Tenet Healthcare (THC): Q4 EPS of $0.52 misses by $0.16. Revenue of $2.33B (+7.3% Y/Y) misses by $0.01B. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Tuesday, February 26, 12:05 AM Notable earnings before Tuesday’s open: AG, AKRX, AMED, AMT, AUXL, AZO, BMO, BYD, CBRL, CIE, CMLP, CRZO, ECL, EXPD, GTI, HD, HFC, M,MFA, PCS, RRD, RSH, SKS, SPRD, SRE, THC, TSL, UNFI, UTHR Comment! [Earnings]
- Monday, February 25, 5:30 PM Notable earnings before Tuesday’s open: AG, AKRX, AMED, AMT, AUXL, AZO, BMO, BYD, CBRL, CIE, CMLP, CRZO, ECL, EXPD, GTI, HD, HFC, M,MFA, PCS, RRD, RSH, SKS, SPRD, SRE, THC, TSL, UNFI, UTHR Comment! [Earnings]
- Thursday, January 24, 12:00 PM In addition to its reaching an agreement with Health Net (HNT +1%) on reimbursement rates, Tenet Healthcare (THC +3.5%) gets an added boost from an upgrade to Outperform at Raymond James. The firm says that despite the run we've already seen in hospital stocks, there's still room for THC. The company has solid free cash flow and its refinancing efforts will only add more that down the road. Additional growth drivers, such as the Conifer health-information business and benefits from the health-care overhaul, should help propel the stock higher over the near term. Comment! [Healthcare, On the Move]
-
- View all 1 replies
-
Michael Bryant: $SNTS has shown up for 2 days in a row (excluding Monday where everything fell). Institutional buying?
-
Jim Van Meerten
$THC - 96% Barchart technical buy signals - 17 new highs and up 21.50% in the last month - Relative Strength Index 81.65% - View all 0 replies
-
- View all 2 replies
-
-
Erick McKitterick: No I left the THC long back on Nov 7th. I both tweeted the trade and put it on SA.
LATEST REPLIES
-
- View all 1 replies
-
Michael Bryant: $SNTS has shown up for 2 days in a row (excluding Monday where everything fell). Institutional buying?
-
- View all 2 replies
-
-
Erick McKitterick: No I left the THC long back on Nov 7th. I both tweeted the trade and put it on SA.
-
- View all 3 replies
-
Bret Kenwell: Hopium isn't THC, though it has similar effects. Mostly Bullish/Bearish distortion..to the bull side. -



